Application | Comment | Organism |
---|---|---|
drug development | overexpression of hepaxadranase in cancers is well known and is associated with angiogenesis, inflammation and increased metastatic potential, making this enzyme a promising drug target | Burkholderia pseudomallei |
Crystallization (Comment) | Organism |
---|---|
wild-type enzyme BpHep, X-ray diffraction structure determination and analysis at 1.60 A resolution, PDB ID 5BWI | Burkholderia pseudomallei |
Protein Variants | Comment | Organism |
---|---|---|
E144A | site-directed mutagenesis, conserved active site residue mutant | Burkholderia pseudomallei |
E255A | site-directed mutagenesis, conserved active site residue mutant | Burkholderia pseudomallei |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
heparan sulfate + H2O | Burkholderia pseudomallei | - |
? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Burkholderia pseudomallei | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
heparan sulfate + H2O | - |
Burkholderia pseudomallei | ? | - |
? | |
heparan sulfate + H2O | enzyme BpHep is specific for heparan sulfate | Burkholderia pseudomallei | ? | - |
? | |
additional information | activity assays using fluorescein isothiocyanate (FITC)-labeled glycosaminoglycans. NMR spectroscopic study of enzyme cleavage site specificity, overview | Burkholderia pseudomallei | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
More | wild-type enzyme BpHep comprises two funcxadtional domains: a catalytic domain consisting of an (alpha/beta)8 barrel and a beta-sandwich C-terminal domain. In the catalytic domain of BpHepwt, amino acid residues Glu144 and Glu255, with commenxadsurate residues highly conserved in hHep, are the catalytic residues, with Glu144 acting as a proton donor and Glu255 as a nucleoxadphile. A canyon-like cleft made up of several polar and nonpolar residue forms a putative binding site. Three-dimensional structure analysis, overview | Burkholderia pseudomallei |
Synonyms | Comment | Organism |
---|---|---|
BpHep | - |
Burkholderia pseudomallei |
endo-beta-glucuronidase | - |
Burkholderia pseudomallei |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
40 | - |
- |
Burkholderia pseudomallei |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
4.5 | - |
- |
Burkholderia pseudomallei |
pH Minimum | pH Maximum | Comment | Organism |
---|---|---|---|
2.5 | 6.5 | activity range, profile overview | Burkholderia pseudomallei |
General Information | Comment | Organism |
---|---|---|
evolution | the enzyme belongs to the glycoxadside hydrolase family 79, GH79, from GH clan A | Burkholderia pseudomallei |
additional information | NMR study of the endo cleavage mechanism of the heparanase, overview. Conserved active site regions, including a His-His-Tyr sequence. The BpHep residues Glu144 and Glu255 are predicted to be located at similar positions postulated for BhHep and are within loops between the beta-strands and alpha-helices, which is typical of TIM-barrel glycoside hydrolases, comparison to the human enzyme | Burkholderia pseudomallei |
physiological function | the enzyme degrades heparan sulfate (HS), a glycosaminoglycan (GAG), by hydrolysis of the beta-1,4-glycosidic linkage between glucuronic acid (GlcUA, G) and alpha-D-glucosamine (GlcN, N) residues. The overexpression of heparanase in cancers is well known and is associated with angiogenesis, inflammation and increased metastatic potential | Burkholderia pseudomallei |